These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

721 related items for PubMed ID: 26247722

  • 1. ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.
    Washington MN, Suh G, Orozco AF, Sutton MN, Yang H, Wang Y, Mao W, Millward S, Ornelas A, Atkinson N, Liao W, Bast RC, Lu Z.
    Cell Death Dis; 2015 Aug 06; 6(8):e1836. PubMed ID: 26247722
    [Abstract] [Full Text] [Related]

  • 2. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells.
    Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, Khare S, Kondo S, Kondo Y, Yu Y, Mills GB, Liao WS, Bast RC.
    J Clin Invest; 2008 Dec 06; 118(12):3917-29. PubMed ID: 19033662
    [Abstract] [Full Text] [Related]

  • 3. The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts.
    Mao W, Peters HL, Sutton MN, Orozco AF, Pang L, Yang H, Lu Z, Bast RC.
    Cancer; 2019 Apr 15; 125(8):1267-1280. PubMed ID: 30620384
    [Abstract] [Full Text] [Related]

  • 4. Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel.
    Zou CF, Jia L, Jin H, Yao M, Zhao N, Huan J, Lu Z, Bast RC, Feng Y, Yu Y.
    BMC Cancer; 2011 Jan 19; 11():22. PubMed ID: 21244707
    [Abstract] [Full Text] [Related]

  • 5. ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7.
    Lu Z, Yang H, Sutton MN, Yang M, Clarke CH, Liao WS, Bast RC.
    Cell Death Differ; 2014 Aug 19; 21(8):1275-89. PubMed ID: 24769729
    [Abstract] [Full Text] [Related]

  • 6. ARHI overexpression induces epithelial ovarian cancer cell apoptosis and excessive autophagy.
    Li J, Cui G, Sun L, Wang SJ, Tian S, Guan Z, Fan WS, Yan ZF, Yang YZ, You YQ, Fu XY, Li LA, Huang K, Li YL, Meng YG.
    Int J Gynecol Cancer; 2014 Mar 19; 24(3):437-43. PubMed ID: 24476894
    [Abstract] [Full Text] [Related]

  • 7. Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition.
    Blessing AM, Santiago-O'Farrill JM, Mao W, Pang L, Ning J, Pak D, Bollu LR, Rask P, Iles L, Yang H, Tran S, Elmir E, Bartholomeusz G, Langley R, Lu Z, Bast RC.
    Cancer; 2020 Aug 01; 126(15):3579-3592. PubMed ID: 32484926
    [Abstract] [Full Text] [Related]

  • 8. Calotropin from Asclepias curasavica induces cell cycle arrest and apoptosis in cisplatin-resistant lung cancer cells.
    Mo EP, Zhang RR, Xu J, Zhang H, Wang XX, Tan QT, Liu FL, Jiang RW, Cai SH.
    Biochem Biophys Res Commun; 2016 Sep 16; 478(2):710-5. PubMed ID: 27498029
    [Abstract] [Full Text] [Related]

  • 9. β-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells.
    Park EJ, Min KJ, Lee TJ, Yoo YH, Kim YS, Kwon TK.
    Cell Death Dis; 2014 May 15; 5(5):e1230. PubMed ID: 24832602
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oncogenic Ras is downregulated by ARHI and induces autophagy by Ras/AKT/mTOR pathway in glioblastoma.
    Zhong C, Shu M, Ye J, Wang X, Chen X, Liu Z, Zhao W, Zhao B, Zheng Z, Yin Z, Gao M, Zhao H, Wang K, Zhao S.
    BMC Cancer; 2019 May 14; 19(1):441. PubMed ID: 31088402
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
    Zhang XY, Zhang M, Cong Q, Zhang MX, Zhang MY, Lu YY, Xu CJ.
    Int J Biochem Cell Biol; 2018 Feb 14; 95():9-16. PubMed ID: 29247711
    [Abstract] [Full Text] [Related]

  • 17. Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation.
    Kao C, Chao A, Tsai CL, Chuang WC, Huang WP, Chen GC, Lin CY, Wang TH, Wang HS, Lai CH.
    Cell Death Dis; 2014 Nov 06; 5(11):e1510. PubMed ID: 25375375
    [Abstract] [Full Text] [Related]

  • 18. MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.
    Pai HC, Kumar S, Shen CC, Liou JP, Pan SL, Teng CM.
    PLoS One; 2015 Nov 06; 10(4):e0123819. PubMed ID: 25874627
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preclinical activity of the liposomal cisplatin lipoplatin in ovarian cancer.
    Casagrande N, Celegato M, Borghese C, Mongiat M, Colombatti A, Aldinucci D.
    Clin Cancer Res; 2014 Nov 01; 20(21):5496-506. PubMed ID: 25231401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.